FDA Inspection
Precare CorpPrecare Corp – FDA Inspection, Oct 9, 2025
Record Details
This FDA Inspection record concerns Precare Corp, with an inspection on October 9, 2025, issued by the New York District Office, covering human drugs.
View Company Profile
ID · 1ef5908d-c4ce-4e5e-8949-5de8d8dd5b9e
Inspection Facts
Voluntary Action Indicated (VAI)
Objectionable conditions were found, but FDA is not prepared to take or recommend regulatory action.
- Inspection number
- 1286418
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
- Outcome
- Form 483 issued
FDA Citations
7- 21 CFR 211.160(b)Scientifically sound laboratory controls
- 21 CFR 211.22(d)Procedures not in writing, fully followed
- 21 CFR 211.160(b)(4)Calibration - at intervals, written program, remedial action
- 21 CFR 211.67(b)Written procedures not established/followed
- 21 CFR 211.166(b)Adequate number of batches on stability
- 21 CFR 211.170(b)Annual visual exams of drug products
- 21 CFR 211.68(b)Computer control of master formula records
Full citation text and observation details available on the Dashboard.
Other FDA inspections of Precare Corp
2| Date | Classification | Office | Project area |
|---|---|---|---|
| September 8, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 15, 2017 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Precare Corp
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.